Description: ChitogenX Inc., an orthopaedic and sports medicine biologics company, engages in the research and development of novel therapeutic soft tissue repair technologies to enhance the success rate of sports medicine surgeries in Canada. It develops Ortho-R, a formulation for rotator cuff repair; Ortho-M, a biopolymer for meniscus repair; Ortho-C, a biopolymer for articular cartilage repair; and Ortho-V, a biopolymer for osteoarthritis healing, as well as ORTHO-T, a biopolymer formulation for tendon healing and regeneration. The company was formerly known as Ortho Regenerative Technologies Inc. and changed its name to ChitogenX Inc. in September 2022. ChitogenX Inc. was incorporated in 2015 and is headquartered in Kirkland, Canada.
Home Page: www.chitogenx.com
16667 Hymus Boulevard
Kirkland,
QC
H9H 4R9
Canada
Phone:
514-782-0951
Officers
| Name | Title |
|---|---|
| Mr. Luc Mainville M.B.A, M.B.A. | Sr. VP & CFO |
| Mr. Guy-Paul Allard | VP of Legal Affairs & Corp. Sec. |
| Mr. Philippe Deschamps | CEO, Pres & Director |
| Mr. Frederic Dumais | Director of Communications & Investor Relations |
| Dr. Jonathan Sackier | Chief Medical Officer |
| Benedek Simo | Controller |
Exchange: OTCQB
Country: US
Currency: US Dollar ($)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0 |
| Price-to-Sales TTM: | 0 |
| IPO Date: | |
| Fiscal Year End: | January |
| Full Time Employees: | 0 |